Search Results

There are 453608 results for: content related to: Eplerenone: A New Aldosterone Receptor Antagonist—Are the FDA's Restrictions Appropriate?

  1. Pharmacokinetics of Eplerenone After Single and Multiple Dosing in Subjects With and Without Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 810–821, Dr William R. Ravis, Ms Susan Reid, Dr Domenic A. Sica and Dr Dwain S. Tolbert

    Article first published online : 25 MAR 2013, DOI: 10.1177/0091270005275894

  2. Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add-On Therapy?

    The Journal of Clinical Pharmacology

    Volume 43, Issue 11, November 2003, Pages: 1203–1210, Dr. L. Michael Prisant, Dr Henry Krum, Dr. Barbara Roniker, Dr. Scott L. Krause, Dr. Kaffa Fakouhi and Dr. Weizhong He

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270003258189

  3. Targeting the aldosterone pathway in cardiovascular disease

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 135–145, Finn Gustafsson, Michel Azizi, Johann Bauersachs, Frederic Jaisser and Patrick Rossignol

    Article first published online : 2 NOV 2011, DOI: 10.1111/j.1472-8206.2011.01004.x

  4. You have free access to this content
    Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  5. Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 289–297, N Fujimura, K Noma, T Hata, J Soga, T Hidaka, N Idei, Y Fujii, S Mikami, T Maruhashi, Y Iwamoto, Y Kihara, K Chayama, H Kato, J K Liao, Y Higashi and ROCK Study Group

    Article first published online : 28 DEC 2011, DOI: 10.1038/clpt.2011.227

  6. You have free access to this content
    Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial

    European Journal of Heart Failure

    Volume 11, Issue 11, November 2009, Pages: 1099–1105, Chris Adamopoulos, Ali Ahmed, Renaud Fay, Michael Angioi, Gerasimos Filippatos, John Vincent, Bertram Pitt, Faiez Zannad and the EPHESUS Investigators

    Article first published online : 29 OCT 2009, DOI: 10.1093/eurjhf/hfp136

  7. Renoprotective effects of mineralocorticoid receptor blockade in heminephrectomized (pro)renin receptor transgenic rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 37, Issue 5-6, May/June 2010, Pages: 569–573, Yuki Mizuguchi, Atsuhiro Ichihara, Yasufumi Seki, Mariyo Sakoda, Asako Kurauchi-Mito, Tatsuya Narita, Kenichiro Kinouchi, Kanako Bokuda and Hiroshi Itoh

    Article first published online : 17 JAN 2010, DOI: 10.1111/j.1440-1681.2010.05360.x

  8. You have free access to this content
    Eplerenone: A Selective Aldosterone Blocker

    Cardiovascular Drug Reviews

    Volume 21, Issue 3, September 2003, Pages: 169–184, Charles T. Stier Jr.

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2003.tb00114.x

  9. You have free access to this content
    Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

    European Journal of Heart Failure

    Volume 16, Issue 2, February 2014, Pages: 143–150, Javaid Iqbal, Yasir Parviz, Bertram Pitt, John Newell-Price, Abdallah Al-Mohammad and Faiez Zannad

    Article first published online : 14 DEC 2013, DOI: 10.1111/ejhf.31

  10. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor

    Clinical and Experimental Pharmacology and Physiology

    Volume 31, Issue 10, October 2004, Pages: 704–709, Fraser M Rogerson, Yizhou Yao, Brian J Smith and Peter J Fuller

    Article first published online : 19 NOV 2004, DOI: 10.1111/j.1440-1681.2004.04079.x

  11. Sex-Specific Impact of Aldosterone Receptor Antagonism on Ventricular Remodeling and Gene Expression after Myocardial Infarction

    Clinical and Translational Science

    Volume 2, Issue 2, April 2009, Pages: 134–142, Rosemeire M. Kanashiro-Takeuchi, Bettina Heidecker, Guillaume Lamirault, Jennifer W. Dharamsi and Joshua M. Hare

    Article first published online : 16 MAR 2009, DOI: 10.1111/j.1752-8062.2009.00094.x

  12. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 6, June 2008, Pages: 492–497, J. H. O’Keefe, H. Abuissa and B. Pitt

    Article first published online : 8 MAY 2007, DOI: 10.1111/j.1463-1326.2007.00730.x

  13. Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure

    Journal of Cardiovascular Electrophysiology

    Volume 17, Issue 5, May 2006, Pages: 534–541, SUNIL C. SHROFF, KYUNGMOO RYU, NICHOLE L. MARTOVITZ, BRIAN D. HOIT and BRUCE S. STAMBLER

    Article first published online : 14 FEB 2006, DOI: 10.1111/j.1540-8167.2006.00372.x

  14. Eplerenone-Mediated Regression of Electrical Activation Delays and Myocardial Fibrosis in Heart Failure

    Journal of Cardiovascular Electrophysiology

    Volume 25, Issue 5, May 2014, Pages: 537–544, CHRISTINE TANAKA-ESPOSITO, SUBHA VARAHAN, DARWIN JEYARAJ, YUAN LU and BRUCE S. STAMBLER

    Article first published online : 10 MAR 2014, DOI: 10.1111/jce.12379

  15. You have free access to this content
    The Use of Aldosterone Receptor Blockers in the Treatment of Hypertension

    The Journal of Clinical Hypertension

    Volume 6, Issue 11, November 2004, Pages: 632–635, Myron H. Weinberger

    Article first published online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2004.03057.x

  16. You have free access to this content
    Anti-inflammatory effects of eplerenone on viral myocarditis

    European Journal of Heart Failure

    Volume 11, Issue 4, April 2009, Pages: 349–353, Jie Xiao, Miho Shimada, Wenling Liu, Dayi Hu and Akira Matsumori

    Article first published online : 29 MAR 2009, DOI: 10.1093/eurjhf/hfp023

  17. EPLERENONE PREVENTS ADVERSE CARDIAC REMODELLING INDUCED BY PRESSURE OVERLOAD IN ATRIAL NATRIURETIC PEPTIDE-NULL MICE

    Clinical and Experimental Pharmacology and Physiology

    Volume 33, Issue 9, September 2006, Pages: 773–779, Veronica Franco, Yiu-Fai Chen, Ji A Feng, Peng Li, Dajun Wang, Erum Hasan, Suzanne Oparil and Gilbert J Perry

    Article first published online : 10 AUG 2006, DOI: 10.1111/j.1440-1681.2006.04434.x

  18. Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

    European Journal of Heart Failure

    Volume 17, Issue 2, February 2015, Pages: 224–232, Bertram Pitt, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faiez Zannad, Christina Nowack, So-Young Kim, Alexander Pieper, Nina Kimmeskamp-Kirschbaum and Gerasimos Filippatos

    Article first published online : 10 FEB 2015, DOI: 10.1002/ejhf.218

  19. You have free access to this content
    Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

    The Journal of Clinical Hypertension

    Volume 6, Issue 4, April 2004, Pages: 175–185, Takao Saruta, 1 Shigeru Kageyama, 2 Toshio Ogihara, 3 Kunio Hiwada, 4 Masayo Ogawa, 5 Kazuji Tawara, 6 Marjorie Gatlin, 7 Susan Garthwaite, 7 Richard Bittman and 8 Jeffrey Patrick 7

    Article first published online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2004.03146.x

  20. You have free access to this content
    Treatment Considerations With Aldosterone Receptor Antagonists

    The Journal of Clinical Hypertension

    Volume 13, Issue 1, January 2011, Pages: 65–69, Domenic A. Sica and John M. Flack

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1751-7176.2010.00377.x